279 related articles for article (PubMed ID: 30127641)
1. Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Liao X; Wang X; Huang K; Yang C; Yu T; Han C; Zhu G; Su H; Huang R; Peng T
Cancer Manag Res; 2018; 10():2537-2551. PubMed ID: 30127641
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
Luo SS; Liao XW; Zhu XD
J Cancer; 2019; 10(25):6298-6313. PubMed ID: 31772663
[No Abstract] [Full Text] [Related]
3. Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma.
Liao X; Zhu G; Huang R; Yang C; Wang X; Huang K; Yu T; Han C; Su H; Peng T
Cancer Manag Res; 2018; 10():787-803. PubMed ID: 29713196
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.
Liao X; Han C; Wang X; Huang K; Yu T; Yang C; Huang R; Liu Z; Han Q; Peng T
Cancer Manag Res; 2018; 10():3255-3271. PubMed ID: 30233242
[TBL] [Abstract][Full Text] [Related]
5. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
[TBL] [Abstract][Full Text] [Related]
6. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
Wang ZX; Deng TX; Ma Z
J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis.
Xin W; Fu Y; Chen L; Ding H; Feng T; Sun J; Qi Y; Hu Y; Fang Q; Fang L
J Gastrointest Oncol; 2023 Apr; 14(2):719-732. PubMed ID: 37201049
[TBL] [Abstract][Full Text] [Related]
8. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
[TBL] [Abstract][Full Text] [Related]
9. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY
Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534
[TBL] [Abstract][Full Text] [Related]
10. A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma.
Lan T; Lu Y; Xiao Z; Xu H; He J; Hu Z; Mao W
PeerJ; 2019; 7():e7353. PubMed ID: 31380150
[TBL] [Abstract][Full Text] [Related]
11. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
12. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Front Oncol; 2019; 9():1207. PubMed ID: 31799184
[TBL] [Abstract][Full Text] [Related]
13. Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Liao X; Huang K; Huang R; Liu X; Han C; Yu L; Yu T; Yang C; Wang X; Peng T
Onco Targets Ther; 2017; 10():4493-4506. PubMed ID: 28979141
[TBL] [Abstract][Full Text] [Related]
14. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
15. Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma.
Ma R; Zhao Y; He M; Zhao H; Zhang Y; Zhou S; Gao M; Di D; Wang J; Ding J; Wei M
Cancer Cell Int; 2019; 19():360. PubMed ID: 31892859
[TBL] [Abstract][Full Text] [Related]
16. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.
Li X; Shi Y; Yin Z; Xue X; Zhou B
J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.
Liu JQ; Liao XW; Wang XK; Yang CK; Zhou X; Liu ZQ; Han QF; Fu TH; Zhu GZ; Han CY; Su H; Huang JL; Ruan GT; Yan L; Ye XP; Peng T
BMC Gastroenterol; 2020 Dec; 20(1):415. PubMed ID: 33302876
[TBL] [Abstract][Full Text] [Related]
19. Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer.
Yin XH; Jin YH; Cao Y; Wong Y; Weng H; Sun C; Deng JH; Zeng XT
Front Oncol; 2019; 9():729. PubMed ID: 31448232
[No Abstract] [Full Text] [Related]
20. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]